It is worth mentioning that this study has revealed the connection between ANXA6 and radiosensitivity for the first time and further implies that ANXA6 may be applied as a new biomarker for the diagnosis and prognosis of NPC radiotherapy. Here, ANXA6 is linked to nasopharyngeal carcinoma.